Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lye M Tho"'
Autor:
Egbert F Smit, Christophe Dooms, Jo Raskin, Ernest Nadal, Lye M Tho, Xiuning Le, Julien Mazieres, How S Hin, Masahire Morise, Viola W Zhu, Daniel Tan, Kristina H Holmberg, Barbara Ellers-Lenz, Svenja Adrian, Sabine Brutlach, Karl M Schumacher, Niki Karachaliou, Yi-Long Wu
Publikováno v:
Future Oncology. 18:1039-1054
MET amplification (METamp), a mechanism of acquired resistance to EGFR tyrosine kinase inhibitors, occurs in up to 30% of patients with non-small-cell lung cancer (NSCLC) progressing on first-line osimertinib. Combining osimertinib with a MET inhibit
Autor:
Egbert, F Smit, Christophe, Dooms, Jo, Raskin, Ernest, Nadal, Lye M, Tho, Xiuning, Le, Julien, Mazieres, How, S Hin, Masahire, Morise, Viola, W Zhu, Daniel, Tan, Kristina, H Holmberg, Barbara, Ellers-Lenz, Svenja, Adrian, Sabine, Brutlach, Karl M, Schumacher, Niki, Karachaliou, Yi-Long, Wu
Publikováno v:
Future oncology (London, England). 18(9)
Osimertinib is used to treat a type of lung cancer that has specific changes (mutations) in a gene called
Autor:
Teck Onn Lim, Matin Mellor Abdullah, Gwo F. Ho, Kwang J. Chong, Kean F. Ho, Kin Wah Leong, Ibrahim A. Wahid, Fuad Ismail, Nur Aishah Taib, Ahmad Kamal Mohamed, Jayendran Dharmaratnam, Emran N. Aina, Gerard Chin Chye Lim, Cheng H. Yip, Chiao M. Lim, Lye M. Tho, Kananathan Ratnavelu, Soon Keat Cheah
Publikováno v:
BMC Cancer
Background Cancer is the leading cause of deaths in the world. A widening disparity in cancer burden has emerged between high income and low-middle income countries. Closing this cancer divide is an ethical imperative but there is a dearth of data on
Autor:
Lim, Gerard C. C., Aina, Emran N., Soon K. Cheah, Ismail, Fuad, Gwo F. Ho, Lye M. Tho, Cheng H. Yip, Taib, Nur A., Kwang J. Chong, Dharmaratnam, Jayendran, Abdullah, Matin M., Mohamed, Ahmad K., Ho, Kean F., Ratnavelu, Kananathan, Lim, Kananathan M., Kin W. Leong, Wahid, Ibrahim A., Lim, Teck O.
Publikováno v:
BMC Cancer; 2014, Vol. 14 Issue 1, p1-16, 16p